Key Highlights

  • GridAI Technologies (NASDAQ:GRDX) reported a nine-month net loss of USD 19.9 million for the period ended September 30, 2026, against USD 3.4 million a year earlier, driven by a USD 10.1 million Goodwill impairment.
  • Third-quarter Revenue was USD 38,110 and nine-month revenue USD 162,194, while nine-month cost of services of USD 805,187 left a gross loss of USD 642,993.
  • Cash was USD 239,834 at September 30, 2026, with a Working Capital Deficit of about USD 11.0 million and an accumulated deficit of about USD 228.0 million.
  • GridAI Technologies (NASDAQ:GRDX) advanced a total of USD 5.0 million to Pronghorn Resources under a secured convertible note and received about USD 11.0 million of financing cash after quarter end.

A USD 10.1 Million Charge on the Grid AI Acquisition

GridAI Technologies (NASDAQ:GRDX), formerly Entero Therapeutics, filed its Quarterly Report on November 16, 2026. The Boca Raton company runs an AI-driven energy optimization business, Grid AI Corp., acquired on September 30, 2025, alongside a legacy gastrointestinal drug program built on Adrulipase for exocrine pancreatic insufficiency. Because the Acquisition closed on the last day of the comparison period, prior-year figures mostly reflect the legacy drug business. Within the nine-month loss, the AI segment booked a goodwill Impairment of USD 10,070,124, and goodwill on the Balance Sheet fell to USD 14.0 million from USD 24.1 million at December 31, 2025.

Tiny Revenue Against Rising Overhead

Revenue was USD 38,110 in the third quarter and USD 162,194 for nine months, compared with none a year earlier. Cost of services of USD 30,849 in the quarter left a Gross Profit of USD 7,261, but the nine-month figure turned into a gross loss of USD 642,993. General and administrative expenses jumped to USD 3.64 million in the quarter from USD 0.93 million, and to USD 9.0 million for nine months from USD 2.4 million. The quarterly net loss was USD 3.42 million, compared with USD 1.15 million, or USD 0.27 per share after non-controlling interests and preferred dividends. The nine-month loss per share was USD 2.36.

Going-Concern Language and Post-Quarter Funding

The filing states that cash of USD 239,834, a working capital deficit of about USD 11.0 million and an accumulated deficit of about USD 228.0 million raise substantial doubt about the company's ability to continue as a going concern. It notes that roughly USD 11.0 million of financing-related cash receipts arrived through November 9, 2026, but says this does not remove the need for more capital. Since quarter end, the company advanced further sums to Pronghorn Resources, a Natural Gas producer, lifting principal to USD 5.0 million under a note maturing by December 31, 2026. It also issued over 2.2 million shares in October, and 10,265,090 shares were outstanding as of November 16, 2026. Nasdaq issued a notice in April 2026 over a late annual report, and the filing says compliance has since been regained.

Where Things Stand

The impairment reflects the carrying value of the Grid AI acquisition being written down by USD 10.1 million, which accounts for about half of the nine-month net loss of USD 19.9 million. GridAI Technologies (NASDAQ:GRDX) still generates very little revenue, has an accumulated deficit of about USD 228.0 million and carries going-concern language, although USD 11.0 million of post-quarter receipts eased near-term pressure. The next markers are revenue growth in the AI segment, repayment of the Pronghorn note by December 31, 2026, any further share issuance and its Nasdaq compliance record.